Use and Misuse of IOPTH Levels During Parathyroidectomy

2008 ◽  
Vol 139 (2_suppl) ◽  
pp. P48-P48
Author(s):  
Melanie Wilson Seybt ◽  
Kelly Loftus ◽  
Kendall Rader ◽  
Anthony Mulloy ◽  
David J Terris

Objective The combined use of localization and intraoperative parathyroid hormone assay (IOPTH) has facilitated the performance of targeted or minimally invasive parathyroidectomy. The precise algorithm of the use of IOPTH has been debated. We sought to clarify the optimal sequence of testing. Methods After IRB approval was obtained, demographic data and intraoperative laboratory and surgical findings from patients undergoing parathyroidectomy were prospectively gathered and analyzed. Specific attention was paid to the value of pre-excision (P-E) values and the 5-minute postoperative (5-min) levels and their impact on intraoperative decision-making. In the first 49 consecutive patients, a P-E baseline value was sought; in all cases a 5-min value was obtained when possible. Results 112 patients underwent parathyroidectomy during the study period. 30 of these were for secondary or tertiary hyperparathyroidism and were excluded. 78 (95.1%) of the patients were eucalcemic. In 4 cases (4.9%), the incorporation of the pre-excision baseline value represented a false positive, and surgery was aborted prematurely. In no case did the P-E value change what was otherwise destined to be a successful result based on pre-incision value. In 47 cases (57.3%), operative time was conserved as the procedure was correctly stopped after the 5-min level. Conclusions Pre-excision baseline levels, while logical in their original proposal, appear to play virtually no role in determining the completeness of an exploration, and may in fact be misleading. A 5-minute postoperative level adds value in over one-half of cases by allowing earlier termination of the operation.

2007 ◽  
Vol 73 (3) ◽  
pp. 281-283 ◽  
Author(s):  
Leila Thanasoulis ◽  
Juliane Bingener ◽  
Kenneth Sirinek ◽  
Melanie Richards

The role of the intraoperative parathyroid hormone (IOPTH) assay in patients with tertiary hyperparathyroidism (3HPT) is not well defined. To evaluate the utility of the IOPTH in 3HPT, we compared its use in 72 patients with primary hyperparathyroidism (1HPT) and 3HPT undergoing parathyroidectomy. Sixty-three patients with 1HPT and nine patients with 3HPT were identified. There were 30 men and 42 women (mean age, 58 years). The mean serum calcium and preoperative intact PTH levels in 1HPT were 11.1 mg/dL and 214 pg/mL compared with 11.2 mg/dL and 849 pg/mL in 3HPT (Ca, non significant; PTH, P < 0.05). Intraoperatively, a solitary abnormal gland was found in 62 of 72 (86%) patients. Seven patients with 3HPT had three- or four-gland hyperplasia. The two groups were compared to determine if a 10-minute postexcision IOPTH decline >50 per cent would have similar success rates. Seventy-one of 72 (98.6%) patients had a >50 per cent decline from the baseline IOPTH at the end of the operation. The average reduction from baseline was 85.3 per cent in 1HPT and 88.6 per cent in 3HPT (not significant). Average follow-up was 9.8 months for 1HPT and 11.1 months in 3HPT. Three of 63 patients (4.8%) with 1HPT and five of nine patients (55.6%) with 3HPT had inappropriate elevations in PTH ( P < 0.05). All patients with 3HPT were normocalcemic compared with 62 of 64 (97%) patients with 1HPT (not significant). The IOPTH assay can be used in 3HPT in an identical fashion with an equivalent rate of normocalcemia compared with its applications in 1HPT.


Sign in / Sign up

Export Citation Format

Share Document